Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States

Severe COVID-19 patients present a clinical and laboratory overlap with other hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH). However, the underlying mechanisms of these conditions remain to be explored. Here, we investigated the transcriptome of 1596 individuals, including patients with COVID-19 in comparison to healthy controls, other acute inflammatory states (HLH, multisystem inflammatory syndrome in children [MIS-C], Kawasaky disease [KD]), and different respiratory infections (seasonal coronavirus, influenza, bacterial pneumonia). We observed that COVID-19 and HLH share immunological pathways (cytokine/chemokine signaling and neutrophil-mediated immune responses), including gene signatures that stratify COVID-19 patients admitted to the intensive care unit (ICU) and COVID-19_nonICU patients. Of note, among the common differentially expressed genes (DEG), there is a cluster of neutrophil-associated genes that reflects a generalized hyperinflamatory state since it is also dysregulated in patients with KD and bacterial pneumonia. These genes are dysregulated at protein level across several COVID-19 studies and form an interconnected network with differentially expressed plasma proteins that point to neutrophil hyperactivation in COVID-19 patients admitted to the intensive care unit. scRNAseq analysis indicated that these genes are specifically upregulated across different leukocyte populations, including lymphocyte subsets and immature neutrophils. Artificial intelligence modeling confirmed the strong association of these genes with COVID-19 severity. Thus, our work indicates putative therapeutic pathways for intervention.

[1]  F. Alqutami,et al.  COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets , 2021, Frontiers in Genetics.

[2]  I. Jurisica,et al.  IID 2021: towards context-specific protein interaction analyses by increased coverage, enhanced annotation and enrichment analysis , 2021, Nucleic Acids Res..

[3]  H. Ochs,et al.  The relationship between autoantibodies targeting GPCRs and the renin-angiotensin system associates with COVID-19 severity , 2021, medRxiv.

[4]  Benjamin S. Glicksberg,et al.  Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children , 2021, Nature Communications.

[5]  Tianyang Mao,et al.  Myeloid dysregulation and therapeutic intervention in COVID-19 , 2021, Seminars in Immunology.

[6]  G. Bowlin,et al.  Patients with COVID-19: in the dark-NETs of neutrophils , 2021, Cell Death & Differentiation.

[7]  I. Jurisica,et al.  The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2–infected patients by sex and age , 2021, JCI insight.

[8]  Shuangge Ma,et al.  Diverse functional autoantibodies in patients with COVID-19 , 2021, Nature.

[9]  K. Sneppen,et al.  The COVID‐19 pandemic: key considerations for the epidemic and its control , 2021, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[10]  Timothy L. Tickle,et al.  COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.

[11]  E. Vazquez,et al.  Analysis workflow of publicly available RNA-sequencing datasets , 2021, STAR Protocols.

[12]  D. Dennison,et al.  Circulating activated neutrophils in COVID-19: An independent predictor for mechanical ventilation and death , 2021, International Journal of Infectious Diseases.

[13]  J. Schultze,et al.  Neutrophils in COVID-19 , 2021, Frontiers in Immunology.

[14]  A. Iafrate,et al.  Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity , 2021, Cell.

[15]  B. Baradaran,et al.  Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy , 2021, Journal of clinical medicine.

[16]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[17]  D. Sin,et al.  COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis , 2021, EClinicalMedicine.

[18]  C. D. Dela Cruz,et al.  A neutrophil activation signature predicts critical illness and mortality in COVID-19 , 2021, Blood Advances.

[19]  Moom R. Roosan,et al.  SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets , 2021, BMC genomics.

[20]  Ricardo Henao,et al.  Dysregulated transcriptional responses to SARS-CoV-2 in the periphery , 2021, Nature Communications.

[21]  Wan-chi Lin,et al.  Regulatory mechanisms of neutrophil migration from the circulation to the airspace , 2021, Cellular and Molecular Life Sciences.

[22]  Y. Xi.  COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue. , 2021, Emerging microbes & infections.

[23]  Luke Y. C. Chen,et al.  COVID-19 cytokine storm syndrome: a threshold concept , 2021, The Lancet Microbe.

[24]  Gregory M. Goldgof,et al.  A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood , 2021, Science Advances.

[25]  Mariam Sarli,et al.  Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers , 2021, EBioMedicine.

[26]  Samsiddhi Bhattacharjee,et al.  Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India , 2021, Infection, Genetics and Evolution.

[27]  S. Gross,et al.  Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab , 2021, Journal of Translational Autoimmunity.

[28]  C. Wouters,et al.  Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019 , 2021, Clinical & translational immunology.

[29]  M. Feldmann,et al.  The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19 , 2020, Med.

[30]  Ashutosh Kumar Singh,et al.  Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis , 2020, United European gastroenterology journal.

[31]  Christel A. S. Bergström,et al.  Proteomics-informed identification of luminal targets for in situ diagnosis of inflammatory bowel disease. , 2020, Journal of pharmaceutical sciences.

[32]  R. Schmid,et al.  Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients , 2020, Scientific Reports.

[33]  M. Serteser,et al.  Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients , 2020, PloS one.

[34]  Givanna H. Putri,et al.  Integrated immune dynamics define correlates of COVID-19 severity and antibody responses , 2020, Cell Reports Medicine.

[35]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[36]  T. Hwang,et al.  Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease , 2020, Frontiers in Pharmacology.

[37]  Dain R. Brademan,et al.  Large-Scale Multi-omic Analysis of COVID-19 Severity , 2020, Cell Systems.

[38]  Samuel M. Brown,et al.  Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study , 2020, The Lancet Rheumatology.

[39]  P. Saldiva,et al.  SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology , 2020, The Journal of experimental medicine.

[40]  A. Gozzetti,et al.  The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 , 2020, Leukemia.

[41]  P. Shi,et al.  In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age , 2020, PLoS biology.

[42]  J. Mason,et al.  A dynamic COVID-19 immune signature includes associations with poor prognosis , 2020, Nature Medicine.

[43]  Madeleine K. D. Scott,et al.  Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans , 2020, Science.

[44]  Alexander Sczyrba,et al.  Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment , 2020, Cell.

[45]  J. Ling,et al.  Increased Neutrophil Respiratory Burst Predicts the Risk of Coronary Artery Lesion in Kawasaki Disease , 2020, Frontiers in Pediatrics.

[46]  Eric Song,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[47]  A. Lesner,et al.  Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS? , 2020, Journal of medicinal chemistry.

[48]  K. Kalantar-Zadeh,et al.  Pharmaco-Immunomodulatory Therapy in COVID-19 , 2020, Drugs.

[49]  Sasikanth Manne,et al.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications , 2020, Science.

[50]  D. Hostallero,et al.  A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19 , 2020, medRxiv.

[51]  S. Fonseca,et al.  Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse , 2020, Frontiers in Immunology.

[52]  G. Sucak,et al.  Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic , 2020, Rheumatology International.

[53]  M. Massari,et al.  Tocilizumab in patients with severe COVID-19: a retrospective cohort study , 2020, The Lancet Rheumatology.

[54]  Yudong D. He,et al.  Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections , 2020, iScience.

[55]  H. Mayani,et al.  Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism , 2020, Archives of Medical Research.

[56]  G. Chatellier,et al.  Anakinra for severe forms of COVID-19: a cohort study , 2020, The Lancet Rheumatology.

[57]  Adam C. Labonte,et al.  Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway , 2020, Scientific Reports.

[58]  R. Schmid,et al.  Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients , 2020 .

[59]  M. Ono,et al.  T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis , 2020, bioRxiv.

[60]  N. Neff,et al.  Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2 , 2020, medRxiv.

[61]  Cezmi A Akdis,et al.  Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19 , 2020, Allergy.

[62]  Amber Dance.  What is a cytokine storm? , 2020 .

[63]  R. Pranata,et al.  Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis , 2020, The American Journal of Emergency Medicine.

[64]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[65]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[66]  H. Ochs,et al.  Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation , 2019, Front. Immunol..

[67]  R. Badolato,et al.  Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature. , 2019, The journal of allergy and clinical immunology. In practice.

[68]  K. Nichols,et al.  Mechanisms of Action of Ruxolitinib in Murine Models of Hemophagocytic Lymphohistiocytosis. , 2019, Blood.

[69]  K. Ley,et al.  Neutrophil Recruitment: From Model Systems to Tissue-Specific Patterns. , 2019, Trends in immunology.

[70]  Randall L. Lindquist,et al.  Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder , 2019, bioRxiv.

[71]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[72]  M. Glogauer,et al.  Neutrophil Diversity in Health and Disease , 2019, Trends in Immunology.

[73]  Othman Soufan,et al.  NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..

[74]  Nuno A. Fonseca,et al.  ArrayExpress update – from bulk to single-cell expression data , 2018, Nucleic Acids Res..

[75]  I. Adcock,et al.  Update on Neutrophil Function in Severe Inflammation , 2018, Front. Immunol..

[76]  C. Hoggart,et al.  Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature , 2018, JAMA pediatrics.

[77]  Y. Aratani.  Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. , 2018, Archives of biochemistry and biophysics.

[78]  Korbinian Strimmer,et al.  A whitening approach to probabilistic canonical correlation analysis for omics data integration , 2018, BMC Bioinformatics.

[79]  Siming Gao.  Cathepsin G and Its Role in Inflammation and Autoimmune Diseases. , 2018, Archives of rheumatology.

[80]  Yan Wang,et al.  Data analytics using canonical correlation analysis and Monte Carlo simulation , 2017, npj Computational Materials.

[81]  Naomi S. Altman,et al.  Points of Significance: Principal component analysis , 2017, Nature Methods.

[82]  JieHao Joshua Sng,et al.  MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD , 2017, COPD.

[83]  Solomon W. Harrar,et al.  Nonparametric Inference for Multivariate Data: The R Package npmv , 2017 .

[84]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[85]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[86]  T. Winkler,et al.  CD83 Modulates B Cell Activation and Germinal Center Responses , 2016, The Journal of Immunology.

[87]  Ludwig A. Hothorn,et al.  nparcomp: An R Software Package for Nonparametric Multiple Comparisons and Simultaneous Confidence Intervals , 2015 .

[88]  S. Catz.  The role of Rab27a in the regulation of neutrophil function , 2014, Cellular microbiology.

[89]  Philippe Bardou,et al.  jvenn: an interactive Venn diagram viewer , 2014, BMC Bioinformatics.

[90]  M. George.  Hemophagocytic lymphohistiocytosis: review of etiologies and management , 2014, Journal of blood medicine.

[91]  J. Barbuto,et al.  Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes , 2014, Journal of leukocyte biology.

[92]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[93]  Walter de Back,et al.  Morpheus: a user-friendly modeling environment for multiscale and multicellular systems biology , 2014, Bioinform..

[94]  O. Ohara,et al.  Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations. , 2013, Human immunology.

[95]  Yingke Xu,et al.  A network of interactions enables CCM3 and STK24 to coordinate UNC13D-driven vesicle exocytosis in neutrophils. , 2013, Developmental cell.

[96]  T. K. van den Berg,et al.  Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations. , 2013, Blood.

[97]  P. Newburger,et al.  Advances in understanding the pathogenesis of HLH , 2013, British journal of haematology.

[98]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[99]  C. Carmona-Rivera,et al.  Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity , 2013, Seminars in Immunopathology.

[100]  Jürgen R. Müller,et al.  Syntaxin 11 is required for NK and CD8+ T‐cell cytotoxicity and neutrophil degranulation , 2013, European journal of immunology.

[101]  P. Humaidan,et al.  (Meta)analyze this: Systematic reviews might lose credibility , 2012, Nature Medicine.

[102]  I. Martín-Loeches,et al.  Critical COPD respiratory illness is linked to increased transcriptomic activity of neutrophil proteases genes , 2012, BMC Research Notes.

[103]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[104]  Shizuo Akira,et al.  Matrix Metalloprotease 9 Mediates Neutrophil Migration into the Airways in Response to Influenza Virus-Induced Toll-Like Receptor Signaling , 2012, PLoS pathogens.

[105]  Wuyuan Lu,et al.  α‐Defensins in human innate immunity , 2012, Immunological reviews.

[106]  Kejian Zhang,et al.  Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis. , 2011, Blood.

[107]  M. Horwitz,et al.  Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.

[108]  N. Satake,et al.  STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America , 2010, Pediatric blood & cancer.

[109]  S. Batra,et al.  Mechanisms of neutrophil accumulation in the lungs against bacteria. , 2010, American journal of respiratory cell and molecular biology.

[110]  Igor Jurisica,et al.  NAViGaTOR: Network Analysis, Visualization and Graphing Toronto , 2009, Bioinform..

[111]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[112]  Markus Ringnér,et al.  What is principal component analysis? , 2008, Nature Biotechnology.

[113]  G. Janka.  Familial and acquired hemophagocytic lymphohistiocytosis , 2006, European Journal of Pediatrics.

[114]  B. Moser.  T-Cell Memory: The Importance of Chemokine-Mediated Cell Attraction , 2006, Current Biology.

[115]  Grégoire Altan-Bonnet,et al.  Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction , 2006, Nature.

[116]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[117]  J. Lora,et al.  Differential expression of inflammatory chemokines by Th1‐ and Th2‐cell promoting dendritic cells: A role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation , 2005, Immunology and cell biology.

[118]  R. Lutter,et al.  Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases , 2005, Clinical and experimental immunology.

[119]  J. Schröder,et al.  Human leukocyte elastase and cathepsin G are specific inhibitors of C5a‐dependent neutrophil enzyme release and chemotaxis , 2004, Experimental dermatology.

[120]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[121]  J. Pohl,et al.  Amino acid sequence of CAP37, a human neutrophil granule‐derived antibacterial and monocyte‐specific chemotactic glycoprotein structurally similar to neutrophil elastase , 1990, FEBS letters.

[122]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[123]  S. Nonoyama,et al.  The Role of Neutrophil Activation in the Pathogenesis of Kawasaki Disease , 2018 .

[124]  Tanya Barrett,et al.  The Gene Expression Omnibus Database , 2016, Statistical Genomics.

[125]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[126]  Jun-Ming Zhang,et al.  Cytokines, Inflammation, and Pain , 2007, International anesthesiology clinics.